UBS ASSET MANAGEMENT AMERICAS INC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$902,020
+123.7%
15,536
+53.0%
0.00%
Q2 2023$403,2780.0%10,1530.0%0.00%
Q1 2023$403,278
+96.9%
10,153
+99.4%
0.00%
Q4 2022$204,851
-99.9%
5,092
-21.5%
0.00%
Q3 2022$208,428,000
-13.5%
6,485
-20.2%
0.00%
Q2 2022$241,009,000
+12.7%
8,123
+6.8%
0.00%
Q1 2022$213,889,000
-39.0%
7,6090.0%0.00%
Q4 2021$350,623,000
+40.4%
7,6090.0%0.00%
Q3 2021$249,729,000
-6.4%
7,6090.0%0.00%
Q2 2021$266,696,000
+8.8%
7,609
+12.2%
0.00%
Q1 2021$245,101,000
+4.7%
6,782
+18.0%
0.00%
Q1 2020$234,092,000
-36.9%
5,746
-4.4%
0.00%
Q4 2019$370,821,000
-27.3%
6,013
-14.1%
0.00%
Q3 2019$510,015,000
+13.9%
6,998
+28.5%
0.00%
Q2 2019$447,661,000
+32.5%
5,446
+13.7%
0.00%
Q1 2019$337,887,000
+791.4%
4,790
+468.9%
0.00%
Q4 2018$37,907,000
+12049.7%
842
-82.1%
0.00%
Q3 2016$312,000
+26.8%
4,700
+6.8%
0.00%
Q2 2016$246,000
+13.4%
4,400
-8.3%
0.00%
Q4 2015$217,000
-20.5%
4,800
+9.1%
0.00%
Q2 2015$273,0004,4000.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders